Literature DB >> 19581

Dopamine receptors in rat striatum and nucleus accumbens; conformational studies using rigid analogues of dopamine.

G N Woodruff, K J Watling, C D Andrews, J A Poat, J D McDermed.   

Abstract

A study was made of the actions of dopamine and of some 2-amino-1,2,3,4-tetrahydronaphthalenes on dopamine-sensitive adenylate cyclase in homogenates of rat striatum and nucleus accumbens. The compounds were also tested for their ability to stimulate motor activity following bilateral injection into the nucleus accumbens of conscious rats. The most active compounds on adenylate cyclase from both striatum and nucleus accumbens were dopamine and 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene(6,7-diOHATN). The 5,6-dihydroxy analogue (5,6-diOHATN) was 50 times less active than 6,7-diOHATN in striatal homogenates and 350 times less active in homogenates of nucleus accumbens. All dihydroxy compounds tested were active in causing stimulation of motor activity, the most active compounds being 6,7-and5,6diOHATN. Both dimethoxy derivatives tested were inactive on the adenylate cyclase and as locomotor stimulants.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 19581     DOI: 10.1111/j.2042-7158.1977.tb11357.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  12 in total

1.  Further studies on dopamine receptors in the brain of Helix aspersa [proceedings].

Authors:  S Batta; R J Walker; G N Woodruff
Journal:  Br J Pharmacol       Date:  1979-05       Impact factor: 8.739

2.  Pharmacological profile of non-hydroxylated and ether derivatives of the potent D2-selective agonist N-0437.

Authors:  J M Jansen; I den Daas; H Rollema; P J Swart; P G Tepper; J B de Vries; A S Horn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-02       Impact factor: 3.000

3.  Effects of the (+) and (-)-enantiomers of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene on dopamine receptors and on dopamine uptake [proceedings].

Authors:  C D Andrews; A Davis; H S Freeman; J D McDermed; J A Poat; G N Woodruff
Journal:  Br J Pharmacol       Date:  1978-11       Impact factor: 8.739

4.  Effect of the (+)-and (-)-enantiomers of sulpiride on ADTN-induced hyperactivity in the rat [proceedings].

Authors:  C D Andrews; G N Woodruff
Journal:  Br J Pharmacol       Date:  1978-11       Impact factor: 8.739

5.  Effect of dihydroxy-2-aminotetralin derivatives on dopamine metabolism in the rat striatum.

Authors:  M G Feenstra; H Rollema; A S Horn; D Dijkstra; C J Grol; B H Westerink; A Westerbrink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-01       Impact factor: 3.000

6.  Effects of dopamine receptor agonists and antagonists in the rat nucleus acumbens [proceedings].

Authors:  S B Freedman; C P Wait; G N Woodruff
Journal:  Br J Pharmacol       Date:  1979-11       Impact factor: 8.739

7.  Neurochemical and behavioural profiles of five dopamine analogues.

Authors:  C Sumners; D Dijkstra; J B de Vries; A S Horn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-07       Impact factor: 3.000

8.  [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalen (ADTN). Regional distribution and in vivo binding after acute and chronic drug treatment.

Authors:  Y Clement-Cormier; C E Smith
Journal:  Neurochem Res       Date:  1980-06       Impact factor: 3.996

9.  Culture requirements for optimal expression of 1 alpha,25-dihydroxyvitamin D3-enhanced thyrotropin secretion.

Authors:  M C d'Emden; J D Wark
Journal:  In Vitro Cell Dev Biol       Date:  1991-03

10.  The uptake and release of [3-H]-2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthlane (ADTN) by striatal nerve terminals.

Authors:  A Davis; P J Roberts; G N Woodruff
Journal:  Br J Pharmacol       Date:  1978-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.